BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12504230)

  • 1. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.
    Broering DC; Hillert C; Krupski G; Fischer L; Mueller L; Achilles EG; Schulte am Esch J; Rogiers X
    J Gastrointest Surg; 2002; 6(6):905-13; discussion 913. PubMed ID: 12504230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
    Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
    Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
    Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
    Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant.
    Aussilhou B; Lesurtel M; Sauvanet A; Farges O; Dokmak S; Goasguen N; Sibert A; Vilgrain V; Belghiti J
    J Gastrointest Surg; 2008 Feb; 12(2):297-303. PubMed ID: 18060468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.
    Shindoh J; Vauthey JN; Zimmitti G; Curley SA; Huang SY; Mahvash A; Gupta S; Wallace MJ; Aloia TA
    J Am Coll Surg; 2013 Jul; 217(1):126-33; discussion 133-4. PubMed ID: 23632095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy: A Better Way to Optimize Liver Hypertrophy Compared to Portal Vein Embolization.
    Laurent C; Fernandez B; Marichez A; Adam JP; Papadopoulos P; Lapuyade B; Chiche L
    Ann Surg; 2020 Aug; 272(2):199-205. PubMed ID: 32675481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
    Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
    BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.
    Hwang S; Lee SG; Ko GY; Kim BS; Sung KB; Kim MH; Lee SK; Hong HN
    Ann Surg; 2009 Apr; 249(4):608-16. PubMed ID: 19300228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future liver remnant growth after various portal vein embolization regimens: a quantitative comparison.
    Biggemann L; Uhlig J; Streit U; Sack H; Guo XC; Jung C; Ahmed S; Lotz J; Müller-Wille R; Seif Amir Hosseini A
    Minim Invasive Ther Allied Technol; 2020 Apr; 29(2):98-106. PubMed ID: 30821547
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization.
    Malinowski M; Stary V; Lock JF; Schulz A; Jara M; Seehofer D; Gebauer B; Denecke T; Geisel D; Neuhaus P; Stockmann M
    Langenbecks Arch Surg; 2015 Feb; 400(2):237-46. PubMed ID: 25559774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases.
    Robles R; Marín C; Lopez-Conesa A; Capel A; Perez-Flores D; Parrilla P
    Eur J Surg Oncol; 2012 Jul; 38(7):586-93. PubMed ID: 22560404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.
    Lehwald-Tywuschik N; Vaghiri S; Schulte Am Esch J; Alaghmand S; Klosterkemper Y; Schimmöller L; Lachenmayer A; Ashmawy H; Krieg A; Topp SA; Rehders A; Knoefel WT
    BMC Surg; 2020 Apr; 20(1):63. PubMed ID: 32252737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: A systematic review and meta-analysis.
    Isfordink CJ; Samim M; Braat MNGJA; Almalki AM; Hagendoorn J; Borel Rinkes IHM; Molenaar IQ
    Surg Oncol; 2017 Sep; 26(3):257-267. PubMed ID: 28807245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic left to right portoportal venous collateral vascular formation in patients undergoing right portal vein ligation.
    van Lienden KP; Hoekstra LT; Bennink RJ; van Gulik TM
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1572-1579. PubMed ID: 23483283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative portal vein embolization for extended hepatectomy.
    Hemming AW; Reed AI; Howard RJ; Fujita S; Hochwald SN; Caridi JG; Hawkins IF; Vauthey JN
    Ann Surg; 2003 May; 237(5):686-91; discussion 691-3. PubMed ID: 12724635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
    Zhang GQ; Zhang ZW; Lau WY; Chen XP
    Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the use of portal vein embolization.
    van Gulik TM; van den Esschert JW; de Graaf W; van Lienden KP; Busch OR; Heger M; van Delden OM; Laméris JS; Gouma DJ
    Dig Surg; 2008; 25(6):436-44. PubMed ID: 19212116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model.
    Wilms C; Mueller L; Lenk C; Wittkugel O; Helmke K; Krupski-Berdien G; Rogiers X; Broering DC
    Ann Surg; 2008 May; 247(5):825-34. PubMed ID: 18438120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?
    Tashiro S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):292-9. PubMed ID: 19333540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.
    Schadde E; Ardiles V; Slankamenac K; Tschuor C; Sergeant G; Amacker N; Baumgart J; Croome K; Hernandez-Alejandro R; Lang H; de Santibaňes E; Clavien PA
    World J Surg; 2014 Jun; 38(6):1510-9. PubMed ID: 24748319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.